Rho
Opportunistic bone-density screening
AI system that analyzes routinely captured x-rays to identify patients at risk of osteoporosis by detecting low bone mineral density; Health Canada licensed and FDA De Novo authorized.
Learn more16 Bit
AIDigital Health & HealthTechToronto, ON
Toronto company selling Rho, a Health Canada-licensed, FDA De Novo-cleared AI system that screens routine x-rays for low bone mineral density, plus Physis, an AI pediatric bone-age assessment tool.
Canadian innovation builds a brighter tomorrow.
About
Company site: 16bit.aiToronto company selling Rho, a Health Canada-licensed, FDA De Novo-cleared AI system that screens routine x-rays for low bone mineral density, plus Physis, an AI pediatric bone-age assessment tool.
16 Bit Inc. is an active federal Business Corporation with registered office in Toronto, Ontario, incorporated 2016-10-13; own site lists an office at 20 Bay St, 11th Floor, Toronto. ised-isde.canada.ca
Rho holds a Health Canada licence and FDA De Novo marketing authorization, and previously received FDA Breakthrough Device status. 16bit.ai
INOVAIT's Focus Fund is contributing up to $2 million toward a 3-year Rho commercialization R&D project, with GE HealthCare Canada and the Canadian Association of Radiologists as partners. 16bit.ai
Cambridge Memorial Hospital became the first hospital in Ontario to proactively screen for low bone mineral density using Rho. 16bit.ai
Products & Services
Company site: 16bit.aiProducts 16 Bit publishes on its own site. Each card links to the page it was taken from.
Physis
Pediatric bone-age assessment
AI-assisted software estimating skeletal maturity from pediatric hand x-rays, validated across four independent peer-reviewed publications.
SourcePartnerships
Publicly announced partnerships.
GE HealthCare / GE Edison AI platform
Rho integrated with GE's Edison AI platform after 16 Bit was selected for GE's Canadian Edison AI accelerator.
Clear Medical Imaging
Offers Rho bone-density screening to its patients.
CAN Health Network
Announced a Rho commercialization project at Sunnybrook Health Sciences Centre.
Government & Grants
Government support actually received. Unpublished amounts are left out.
INOVAIT Focus Fund — Rho commercialization-focused R&D
CanExport, National Research Council Canada
Recent News
- Jan 26, 2024Contract
Cambridge Memorial Hospital is the first in Ontario to proactively screen for low bone density
Cambridge Memorial Hospital became the first hospital in Ontario to proactively screen patients for low bone mineral density using 16 Bit's Rho system.
- Jan 18, 2023Government
Rho commercialization-focused R&D Projects to receive up to $2 million of support from INOVAIT Focus Fund
INOVAIT's Focus Fund is contributing up to $2 million toward a 3-year, roughly $6 million project for product iteration and clinical evidence generation to support Rho's clinical adoption, with GE HealthCare Canada and the Canadian Association of Radiologists as partners.
Technology Focus
Company site: 16bit.aiTerms the company uses about its own work.
Opportunistic AI screeningMedical imaging AIBone density screening
Similar Companies
Other companies in AI.
